J. Inorg. Biochem.
Synthesis, crystal structure and leishmanicidal activity of new trimethoprim Ru(III), Cu(II) and Pt(II) metal complexes.
Silva GL, Dias JSM, Silva HVR, Teixeira JDS, De Souza IRB, Guimarães ET, de Magalhães Moreira DR, Soares MBP, Barbosa MIF, Doriguetto AC
Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania, which has very limited treatment options and affects poor and underde ...
Read More
Source: PubMed
Trends Parasitol. 2020 Jan 28
Iron and Heme Metabolism at the Leishmania-Host Interface.
Laranjeira-Silva MF, Hamza I, Pérez-Victoria JM
Species of the protozoan Leishmania are causative agents of human leishmaniasis, a disease that results in significant death, disability, and disfigur ...
Read More
Source: PubMed
Microb. Pathog.
Cellular localization, cloning and expression of Leishmania braziliensis Phospholipase A1.
Bott E, López MG, Lammel EM, Carfagna IE, Durante de Isola EL, Ruybal P, Taboga O, Gimenez G, Belaunzarán ML
Leishmaniasis is caused by several species of protozoan parasites of the genus Leishmania and represents an important global health problem. Leishmani ...
Read More
Source: PubMed
Exp. Parasitol. 2020 Jan 28
Leishmanicidal activity of Piper marginatum Jacq. from Santarém-PA against Leishmania amazonensis.
Macedo CG, Fonseca MY, Caldeira AD, Pinto de Castro S, Lima WP, Gonçalves Borsodi MP, Sartoratto A, Nascimento da Silva M, Salgado CG, Bergmann BR, Ferreira Castro KC
Leishmaniasis is an infectious disease that has high endemicity and is among the six parasitic diseases of higher occurrence in the world. The current ...
Read More
Source: PubMed
Curr Drug Targets 2020 Jan 27
Unveiling the targets involved in quest of antileishmanial leads using in-silico methods.
Boniface PK, Sano CM, Elizabeth FI
Leishmaniasis is a neglected tropical disease associated with several clinical manifestations, including cutaneous, mucocutaneous, and visceral forms. ...
Read More
Source: PubMed
J. Inorg. Biochem.
Synthesis, crystal structure and leishmanicidal activity of new trimethoprim Ru(III), Cu(II) and Pt(II) metal complexes.
Silva GL, Dias JSM, Silva HVR, Teixeira JDS, De Souza IRB, Guimarães ET, de Magalhães Moreira DR, Soares MBP, Barbosa MIF, Doriguetto AC
Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania, which has very limited treatment options and affects poor and underde ...
Read More
Source: PubMed
Trends Parasitol. 2020 Jan 28
Iron and Heme Metabolism at the Leishmania-Host Interface.
Laranjeira-Silva MF, Hamza I, Pérez-Victoria JM
Species of the protozoan Leishmania are causative agents of human leishmaniasis, a disease that results in significant death, disability, and disfigur ...
Read More
Source: PubMed
Microb. Pathog.
Cellular localization, cloning and expression of Leishmania braziliensis Phospholipase A1.
Bott E, López MG, Lammel EM, Carfagna IE, Durante de Isola EL, Ruybal P, Taboga O, Gimenez G, Belaunzarán ML
Leishmaniasis is caused by several species of protozoan parasites of the genus Leishmania and represents an important global health problem. Leishmani ...
Read More
Source: PubMed
Exp. Parasitol. 2020 Jan 28
Leishmanicidal activity of Piper marginatum Jacq. from Santarém-PA against Leishmania amazonensis.
Macedo CG, Fonseca MY, Caldeira AD, Pinto de Castro S, Lima WP, Gonçalves Borsodi MP, Sartoratto A, Nascimento da Silva M, Salgado CG, Bergmann BR, Ferreira Castro KC
Leishmaniasis is an infectious disease that has high endemicity and is among the six parasitic diseases of higher occurrence in the world. The current ...
Read More
Source: PubMed
Curr Drug Targets 2020 Jan 27
Unveiling the targets involved in quest of antileishmanial leads using in-silico methods.
Boniface PK, Sano CM, Elizabeth FI
Leishmaniasis is a neglected tropical disease associated with several clinical manifestations, including cutaneous, mucocutaneous, and visceral forms. ...
Read More
Source: PubMed
